Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: Implication for the backdoor pathway to dihydrotestosterone

被引:123
作者
Homma, Keiko
Hasegawa, Tomonobu
Nagai, Toshiro
Adachi, Masanori
Horikawa, Reiko
Fujiwara, Ikuma
Tajima, Toshihiro
Takeda, Ryoujun
Fukami, Maki
Ogata, Tsutomu
机构
[1] Natl Res Inst Child Hlth & Dev, Dept Endocrinol & Metabol, Tokyo 1578535, Japan
[2] Keio Univ, Sch Med, Dept Lab Med, Tokyo 1608582, Japan
[3] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan
[4] Dokkyo Univ, Koshigaya Hosp, Sch Med, Dept Pediat, Koshigaya 3438555, Japan
[5] Kanagawa Childrens Med Ctr, Div Endocrinol & Metab, Yokohama, Kanagawa 2328555, Japan
[6] Natl Ctr Child Hlth & Dev, Div Endocrinol & Metab, Tokyo 1578535, Japan
[7] Hokkaido Univ, Sch Med, Dept Pediat, Sendai, Miyagi 9800878, Japan
[8] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan
[9] Shirakawa Kousei Gen Hosp, Dept Pediat, Shirakawa, Japan
[10] Natl Res Inst Child Hlth & Dev, Dept Endocrinol, Tokyo 1578535, Japan
关键词
D O I
10.1210/jc.2005-2460
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Context: Although the "backdoor" pathway to dihydrotestosterone has been postulated in the fetal-to-early-infantile period of patients with cytochrome P450 oxidoreductase deficiency (PORD), clinical data in support of this pathway remain limited. Objective: The objective of this study was to obtain clinical evidence for the presence of the backdoor pathway in PORD. Setting: This was a collaboration study between laboratories and hospitals. Subjects: Twenty-two Japanese patients with molecularly confirmed PORD and 1763 control subjects participated in this study. Intervention: Urine steroid profile analysis was performed by gas chromatography/mass spectrometry. In five patients and 776 control subjects, urine samples were obtained before 12 months of age. Main Outcome Measure: The main outcome measure was identification of a urine steroid(s) indicating the backdoor pathway. Results: In the PORD patients, pregnanediol, pregnanetriolone, and pregnanetriol were obviously elevated, and the urine steroid ratios reflecting CYP17A1 and CYP21A2 activities were decreased throughout the examined ages. Furthermore, etiocholanolone and 11-hydroxyandrosterone, which should originate almost exclusively from androstenedione in the conventional "frontdoor" pathway, were grossly normal or somewhat decreased since early infancy, whereas androsterone, which can be derived not only from androstenedione and dihydrotestosterone in the conventional frontdoor pathway but also from 5 alpha-pregnane-3 alpha, 17 alpha-diol-20-one in the backdoor pathway, was increased during early infancy and remained grossly normal thereafter. Thus, the androsterone to etiocholanolone ratio was increased during early infancy and remained grossly normal thereafter. 5 alpha-Pregnane-3 alpha,17 alpha-diol-20-one was elevated throughout the examined ages. Conclusions: The increased androsterone excretion during early infancy, as compared with the etiocholanolone and 11-hydroxyandrosterone excretions in the same period, suggests the presence of the backdoor pathway in PORD.
引用
收藏
页码:2643 / 2649
页数:7
相关论文
共 19 条
[1]
Compound heterozygous mutations of cytochrome p450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome [J].
Adachi, M ;
Tachibana, K ;
Asakura, Y ;
Yamamoto, T ;
Hanaki, K ;
Oka, A .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 128A (04) :333-339
[2]
Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study [J].
Arlt, W ;
Walker, EA ;
Draper, N ;
Ivison, HE ;
Ride, JP ;
Hammer, F ;
Chalder, SM ;
Borucka-Mankiewicz, M ;
Hauffa, BP ;
Malunowicz, EM ;
Stewart, PM ;
Shackleton, CHL .
LANCET, 2004, 363 (9427) :2128-2135
[3]
The backdoor pathway to dihydrotestosterone [J].
Auchus, RJ .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (09) :432-438
[4]
Undetectable maternal serum uE3 and postnatal abnormal sterol and steroid metabolism in Antley-Bixler syndrome [J].
Cragun, DL ;
Trumpy, SK ;
Shackleton, CHL ;
Kelley, RI ;
Leslie, ND ;
Mulrooney, NP ;
Hopkin, RJ .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 129A (01) :1-7
[5]
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome [J].
Flück, CE ;
Tajima, T ;
Pandey, AV ;
Arlt, W ;
Okuhara, K ;
Verge, CF ;
Jabs, EW ;
Mendonça, BB ;
Fujieda, K ;
Miller, WL .
NATURE GENETICS, 2004, 36 (03) :228-230
[6]
Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: Diagnostic value of urine steroid hormone analysis [J].
Fukami, M ;
Hasegawa, T ;
Horikawa, R ;
Ohashi, T ;
Nishimura, G ;
Homma, K ;
Ogata, T .
PEDIATRIC RESEARCH, 2006, 59 (02) :276-280
[7]
Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: Molecular and clinical studies in 10 patients [J].
Fukami, M ;
Horikawa, R ;
Nagai, T ;
Tanaka, T ;
Naiki, Y ;
Sato, N ;
Okuyama, T ;
Nakai, H ;
Soneda, S ;
Tachibana, K ;
Matsuo, N ;
Sato, S ;
Homma, K ;
Nishimura, G ;
Hasegawa, T ;
Ogata, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :414-426
[8]
FUSHER DA, 2002, WILLIAMS TXB ENDOCRI, P811
[9]
Commentary - Estrogen consequences and implications of human mutations in synthesis and action [J].
Grumbach, MM ;
Auchus, RJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (12) :4677-4694
[10]
GRUMBACH MM, 2002, WILLIAMS TXB ENDOCRI, P842